Diabetics, advocates react to insulin price reductions
Major pharmaceutical companies have rolled out plans for insulin price reductions. Diabetics and advocates are grateful but skeptical.
Read MoreMajor pharmaceutical companies have rolled out plans for insulin price reductions. Diabetics and advocates are grateful but skeptical.
Read MoreThe short answer? A lot.
Read MoreIn recent years, those with Type 1 diabetes have seen a greater variety of treatment options at a greater cost. It’s Diabetes Awareness Month 2018, and these patients are ready for a cure.
Read More